Erythro Pharma has rich experience in servicing large scale custom manufacturing needs of global customers in pharmaceuticals, agrochemicals, specialty and fine chemicals. We offer fully integrated contract development and manufacturing services from product development to commercial scale. Erythro Pharma makes every product exclusively for a specific customer and does not sell the same product to other customers. Our business growth has been based on high quality, sustainable and safe production capability, affordable prices and proven track record of completing projects on time. Erythro Pharma has high quality manufacturing assets which can be used for a broad range of fine chemical applications and has extensive fast track new product introduction, project design and delivery experience. Our business thrives on the deep technical strengths established over the last 30+ years in the process development and manufacturing of complex advanced intermediates for APIs, speciality and fine chemicals.
Our goal is to develop and execute cost effective commercial scale manufacturing processes for the better future.
Our philosophy is to bring innovative technologies in cost effective and safe way to provide high quality products to our global customers.
D. Rajagopala Reddy, M.Sc, Ph.D
Founder, Chairman and Chief R&D Officer
Prior to establish Erythro Pharma, he worked as R&D Chief of Standard Organics, formerly the parent organization Dr.Reddy's Laboratories, Before he start his industrial carrier, he did Postdoctoal Research in Organic Synthesis at the University of Wisconsin, Madison, USA. Also he completed his Ph.D at the National Chemical Laboratory, Pune, India under the guidence of Padma Bhushan awardee Dr. A.V. Ramaro. He played a key role in establishing Hyderabad as a Pharma Hub of India. He has vast expertise in taking products from laboratory scale to viable commercial large scale production. Especially, under his guidence developed and optimized a number of successful process for advanced APIs key intermediates, speciality and fine chemicals in cost effective way for commercial scale manufacturing.
D. Balachandra Reddy, B.Com, CA
Co-Founder, Director and Chief Financial Officer
He is one of the Co-Founder of Erythro Pharma. He has been taking care of all financial matters since inception of the company. Also he manages accruals for future facility upgrades and projects. Prior to establish Erythro Phrama, He completed his B. Com and Chartered Accountant cources from the University of Madras, Chennai, India.
N. Chandrasekhar Reddy, M.Sc, Ph.D
Director, Business Development
He has an experience over 16 years in the field of synthetic organic chemistry. Also he is a founder and CEO of SynInnova Laboratories Inc Edmonton, Canada and has been oparating since 2008. Prior to establishing SynInnova, he was a senior scientist and team leader in two large CRO's. He assumed multiple roles during large collaborations with leading pharmaceutical and biotechnology companies like Pfizer, Merck, Gilead Sciences and Anacor. Prior to joining industry, he worked as an NSERC-NRC visiting fellow for two years with Dr. Prabhat Arya's group in the Chemical Biology program at the Steacie Institute of Molecular Sciences in Ottawa, Canada. After completing his graduate studies, he initially worked for two years with Late Professor. A. Srikrishna's group, Indian Institute of Science, Bangalore, India, on the total synthesis of natural products and synthetic methodologies.
D. Abhiram, BS, MS
Director of Operations
Abhiram joined the Erythro Pharma Organization in 2013 after gaining Industrial Quality Assurance & Control experience in the USA. He optimized the systems and processes to improve productivity and efficiency. He has been instrumental in converting necessary manufacturing processes to be in compliance with cGMP guidelines at the facility. He drives corporate social responsibility initiatives of the company. Abhiram completed his BS & MS in Industrial Engineering from the Purdue University, USA.
Satyam S. Nampalli, M.Sc, Ph.D
Chief Scientific Advisor
Dr. Satyam S. Nampalli received his Ph.D., in Organic Chemistry at National Chemical Laboratory, Pune, India. He pursued his Postdoctoral Research at Madison, WI and Athens, GA, USA on the synthesis of Natural Products, anti-HIV and anti-Cancer drugs.
Dr. Nampalli has over 30 years of experience in the field of Biotech and Pharmaceutical Industry. He is a founding partner and COO of American BioInnovations LLC, Sparks, MD, USA and has been operating since 2012. Dr. Nampalli serves as a Scientific Advisory Board Member @ both Erythro & SynInnova Organizations further making a successful Erythro-ABI-SynInnova Triad Partnership in Small Molecule Drug Intermediates, APIs, & Custom Synthesis. Prior to establishing American BioInnovations, he worked in various reputed organizations as briefly mentioned below:
Senior Manager: At Life Technologies on AGT Cell Culture Media Supplements and Reagents.
Program Manager: At BD in the field of Cell Culture & Stem Cell Culture Area for Bio-Pharmaceuticals Production.
Consultant: At Lonza on Cell Culture Media & Troubleshooting.
Program Manager: At J & J Biophamaceuticals
Director of Chemistry: At Apicore for Small Molecule Drugs' Development & APIs productions.
Senior Scientist and Manager: At Amersham Biosciences on various Nucleosides, Nucleotides & DNA Sequencing Chemistry Technology, which enabled the Whole Human Genome Sequencing Efforts.